Overview

CKD-355 Drug-drug Interaction Study (CKD-355 DDI P1)

Status:
Completed
Trial end date:
2018-06-04
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate a pharmacokinetic drug interaction between D797 of D324 in healthy volunteers
Phase:
Phase 1
Details
Lead Sponsor:
Chong Kun Dang Pharmaceutical
Treatments:
Donepezil
Memantine